View in EDS HTML Full Text PDF Full Text

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS Q61R/K/L Mutant Melanoma (TraMel-WT).

Saved in:
Bibliographic Details
Title: A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS Q61R/K/L Mutant Melanoma (TraMel-WT).
Authors: Awada, Gil1 (AUTHOR) gil.awada@uzbrussel.be, Schwarze, Julia Katharina1 (AUTHOR) juliakatharina.schwarze@uzbrussel.be, Tijtgat, Jens1 (AUTHOR) jens.tijtgat@uzbrussel.be, Fasolino, Giuseppe2 (AUTHOR) giuseppe.fasolino@uzbrussel.be, Everaert, Hendrik3 (AUTHOR) hendrik.everaert@uzbrussel.be, Neyns, Bart1 (AUTHOR) bart.neyns@uzbrussel.be, Moulin, Alexandre (AUTHOR), Michielin, Olivier (AUTHOR), Baldi, Alfonso (AUTHOR)
Source: Cancers. May2021, Vol. 13 Issue 9, p2010-2010. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 150367774
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS Q61R/K/L Mutant Melanoma (TraMel-WT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Awada%2C+Gil%22">Awada, Gil</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> gil.awada@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Schwarze%2C+Julia+Katharina%22">Schwarze, Julia Katharina</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> juliakatharina.schwarze@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Tijtgat%2C+Jens%22">Tijtgat, Jens</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jens.tijtgat@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Fasolino%2C+Giuseppe%22">Fasolino, Giuseppe</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> giuseppe.fasolino@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Everaert%2C+Hendrik%22">Everaert, Hendrik</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> hendrik.everaert@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Neyns%2C+Bart%22">Neyns, Bart</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> bart.neyns@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Moulin%2C+Alexandre%22">Moulin, Alexandre</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Michielin%2C+Olivier%22">Michielin, Olivier</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baldi%2C+Alfonso%22">Baldi, Alfonso</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. May2021, Vol. 13 Issue 9, p2010-2010. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=150367774
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers13092010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 2010
    Titles:
      – TitleFull: A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS Q61R/K/L Mutant Melanoma (TraMel-WT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Awada, Gil
      – PersonEntity:
          Name:
            NameFull: Schwarze, Julia Katharina
      – PersonEntity:
          Name:
            NameFull: Tijtgat, Jens
      – PersonEntity:
          Name:
            NameFull: Fasolino, Giuseppe
      – PersonEntity:
          Name:
            NameFull: Everaert, Hendrik
      – PersonEntity:
          Name:
            NameFull: Neyns, Bart
      – PersonEntity:
          Name:
            NameFull: Moulin, Alexandre
      – PersonEntity:
          Name:
            NameFull: Michielin, Olivier
      – PersonEntity:
          Name:
            NameFull: Baldi, Alfonso
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 20726694
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1